[A case of a giant rectal gastrointestinal stromal tumor radically resectable after treatment with neoadjuvant imatinib mesylate]

Gan To Kagaku Ryoho. 2013 Jul;40(7):937-41.
[Article in Japanese]

Abstract

A 64-year-old male patient was diagnosed with rectal gastrointestinal stromal tumor(GIST)by prostate biopsy, because of high PSA. We considered that a radical operation was impossible because the tumor occupied the pelvis, and we suspected prostate invasion. After neoadjuvant chemotherapy(imatinib mesylate 400 mg/day), the tumor size was reduced(90×85 mm→60×50mm), and we could thus perform radical resection. The patient is currently receiving adjuvant chemotherapy (imatinib mesylate 400 mg/day), without recurrence.

Publication types

  • Case Reports
  • English Abstract
  • Review

MeSH terms

  • Antinematodal Agents / therapeutic use*
  • Benzamides / therapeutic use*
  • Gastrointestinal Stromal Tumors / drug therapy*
  • Gastrointestinal Stromal Tumors / pathology
  • Gastrointestinal Stromal Tumors / surgery
  • Humans
  • Imatinib Mesylate
  • Male
  • Middle Aged
  • Neoadjuvant Therapy*
  • Neoplasm Invasiveness
  • Piperazines / therapeutic use*
  • Pyrimidines / therapeutic use*
  • Rectal Neoplasms / drug therapy*
  • Rectal Neoplasms / pathology
  • Rectal Neoplasms / surgery
  • Tomography, X-Ray Computed

Substances

  • Antinematodal Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate